GDF11 improves tubular regeneration after acute kidney injury in elderly mice

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhang, Ying ^a,b   Li, Qinggang ^a   Liu, Dong ^a,c   Huang, Qi ^a   Cai, Guangyan ^a   Cui, Shaoyuan ^a   Sun, Xuefeng ^a   Chen, Xiangmei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b NANKAI UNIVERSITY   (China)

^c AIR FORCE GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; GDF11 PROTEIN, MOUSE; GROWTH DIFFERENTIATION FACTOR;

ACUTE KIDNEY FAILURE; AGING; ANIMAL; CELL DEDIFFERENTIATION; CELL MOTION; CELL PROLIFERATION; KIDNEY TUBULE; MAPK SIGNALING; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; REGENERATION; REPERFUSION INJURY;

ACUTE KIDNEY INJURY; AGING; ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DEDIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; GROWTH DIFFERENTIATION FACTORS; KIDNEY TUBULES; MAP KINASE SIGNALING SYSTEM; MICE; REGENERATION; REPERFUSION INJURY;

EID: 84989815928     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep34624     Document Type: Article

References (38)

1. Hsu, R. K., McCulloch, C. E., Dudley, R. A., Lo, L. J. & Hsu, C. Y. Temporal changes in incidence of dialysis-requiring AKI. Journal of the American Society of Nephrology: JASN 24, 37-42, doi: 10.1681/ASN.2012080800 (2013).
2. Schmitt, R., Marlier, A. & Cantley, L. G. Zag expression during aging suppresses proliferation after kidney injury. Journal of the American Society of Nephrology: JASN 19, 2375-2383, doi: 10.1681/ASN.2008010035 (2008).
3. Miya, M. et al. Age-related decline in label-retaining tubular cells: implication for reduced regenerative capacity after injury in the aging kidney. American journal of physiology. Renal physiology 302, F694-F702, doi: 10.1152/ajprenal.00249.2011 (2012).
4. Schmitt, R. et al. Recovery of kidney function after acute kidney injury in the elderly: a systematic review and meta-analysis. American journal of kidney diseases: the official journal of the National Kidney Foundation 52, 262-271, doi: 10.1053/j. ajkd.2008.03.005 (2008).
5. Berger, K. et al. Origin of regenerating tubular cells after acute kidney injury. Proceedings of the National Academy of Sciences of the United States of America 111, 1533-1538, doi: 10.1073/pnas.1316177111 (2014).
6. Kusaba, T., Lalli, M., Kramann, R., Kobayashi, A. & Humphreys, B. D. Differentiated kidney epithelial cells repair injured proximal tubule. Proceedings of the National Academy of Sciences of the United States of America 111, 1527-1532, doi: 10.1073/ pnas.1310653110 (2014).
7. Harrison, C. A., Al-Musawi, S. L. & Walton, K. L. Prodomains regulate the synthesis, extracellular localisation and activity of TGFbeta superfamily ligands. Growth Factors 29, 174-186, doi: 10.3109/08977194.2011.608666 (2011).
8. Essalmani, R. et al. In vivo functions of the proprotein convertase PC5/6 during mouse development: Gdf11 is a likely substrate. Proceedings of the National Academy of Sciences of the United States of America 105, 5750-5755, doi: 10.1073/pnas.0709428105 (2008).
9. Ge, G., Hopkins, D. R., Ho, W. B. & Greenspan, D. S. GDF11 forms a bone morphogenetic protein 1-activated latent complex that can modulate nerve growth factor-induced differentiation of PC12 cells. Molecular and cellular biology 25, 5846-5858, doi: 10.1128/ mcb.25.14.5846-5858.2005 (2005).
10. Loffredo, F. S. et al. Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell 153, 828-839, doi: 10.1016/j.cell.2013.04.015 (2013).
11. Sinha, M. et al. Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science 344, 649-652, doi: 10.1126/science.1251152 (2014).
12. Egerman, M. A. et al. GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration. Cell metabolism 22, 164-174, doi: 10.1016/j.cmet.2015.05.010 (2015).
13. Smith, S. C. et al. GDF11 Does Not Rescue Aging-Related Pathological Hypertrophy. Circulation research, doi: 10.1161/ CIRCRESAHA.115.307527 (2015).
14. Olson, K. A. et al. Association of growth differentiation factor 11/8, putative anti-ageing factor, with cardiovascular outcomes and overall mortality in humans: analysis of the Heart and Soul and HUNT3 cohorts. European heart journal, doi: 10.1093/eurheartj/ ehv385 (2015).
15. Esquela, A. F. & Lee, S. J. Regulation of metanephric kidney development by growth/differentiation factor 11. Dev Biol 257, 356-370 (2003).
16. Jones, J. et al. Gene signatures of progression and metastasis in renal cell cancer. Clinical cancer research: an official journal of the American Association for Cancer Research 11, 5730-5739, doi: 10.1158/1078-0432.CCR-04-2225 (2005).
17. Hesketh, E. E. et al. Renal ischaemia reperfusion injury: a mouse model of injury and regeneration. Journal of visualized experiments: JoVE, doi: 10.3791/51816 (2014).
18. Poggioli, T. et al. Circulating Growth Differentiation Factor 11/8 Levels Decline with Age. Circulation research, doi: 10.1161/ circresaha.115.307521 (2015).
19. Rodgers, B. D. & Eldridge, J. A. Reduced Circulating GDF11 Is Unlikely Responsible for Age-dependent Changes in Mouse Heart, Muscle, and Brain. Endocrinology, en20151628, doi: 10.1210/en.2015-1628 (2015).
20. Ahn, S. T., Suh, S. I., Moon, H. & Hyun, C. Evaluation of growth differentiation factor 11 (GDF11) levels in dogs with chronic mitral valve insufficiency. Canadian journal of veterinary research= Revue canadienne de recherche veterinaire 80, 90-92 (2016).
21. Harper, S. C. et al. Is Growth Differentiation Factor 11 a Realistic Therapeutic for Aging-Dependent Muscle Defects? Circulation research 118, 1143-1150, doi: 10.1161/circresaha.116.307962 (2016).
22. Walker, R. G. et al. Biochemistry and Biology of GDF11 and Myostatin: Similarities, Differences, and Questions for Future Investigation. Circulation research 118, 1125-1142, doi: 10.1161/circresaha.116.308391 (2016).
23. Zhou, Y. et al. Circulating Concentrations of Growth Differentiation Factor 11 Are Heritable and Correlate With Life Span. The journals of gerontology. Series A, Biological sciences and medical sciences, doi: 10.1093/gerona/glv308 (2016).
24. Schafer, M. J. et al. Quantification of GDF11 and Myostatin in Human Aging and Cardiovascular Disease. Cell metabolism 23, 1207-1215, doi: 10.1016/j.cmet.2016.05.023 (2016).
25. Humphreys, B. D. et al. Intrinsic epithelial cells repair the kidney after injury. Cell stem cell 2, 284-291, doi: 10.1016/j. stem.2008.01.014 (2008).
26. Cirio, M. C., de Groh, E. D., de Caestecker, M. P., Davidson, A. J. & Hukriede, N. A. Kidney regeneration: common themes from the embryo to the adult. Pediatric nephrology (Berlin, Germany) 29, 553-564, doi: 10.1007/s00467-013-2597-2 (2014).
27. Massague, J. TGFbeta signalling in context. Nature reviews. Molecular cell biology 13, 616-630, doi: 10.1038/nrm3434 (2012).
28. Meng, X. M. et al. Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis. Journal of the American Society of Nephrology: JASN 21, 1477-1487, doi: 10.1681/asn.2009121244 (2010).
29. Sugimoto, H. et al. Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Nature medicine 18, 396-404, doi: 10.1038/nm.2629 (2012).
30. Chen, J., Chen, J. K. & Harris, R. C. Deletion of the epidermal growth factor receptor in renal proximal tubule epithelial cells delays recovery from acute kidney injury. Kidney international 82, 45-52, doi: 10.1038/ki.2012.43 (2012).
31. Jang, H. S. et al. Activation of ERK accelerates repair of renal tubular epithelial cells, whereas it inhibits progression of fibrosis following ischemia/reperfusion injury. Biochimica et biophysica acta 1832, 1998-2008, doi: 10.1016/j.bbadis.2013.07.001 (2013).
32. Arany, I., Megyesi, J. K., Nelkin, B. D. & Safirstein, R. L. STAT3 attenuates EGFR-mediated ERK activation and cell survival during oxidant stress in mouse proximal tubular cells. Kidney international 70, 669-674, doi: 10.1038/sj.ki.5001604 (2006).
33. Gall, J. M. et al. Conditional knockout of proximal tubule mitofusin 2 accelerates recovery and improves survival after renal ischemia. Journal of the American Society of Nephrology: JASN 26, 1092-1102, doi: 10.1681/asn.2014010126 (2015).
34. Harrisingh, M. C. et al. The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation. The EMBO journal 23, 3061-3071, doi: 10.1038/sj.emboj.7600309 (2004).
35. Ischenko, I., Zhi, J., Moll, U. M., Nemajerova, A. & Petrenko, O. Direct reprogramming by oncogenic Ras and Myc. Proceedings of the National Academy of Sciences of the United States of America 110, 3937-3942, doi: 10.1073/pnas.1219592110 (2013).
36. Yokoe, T. et al. Clinical significance of growth differentiation factor 11 in colorectal cancer. International journal of oncology 31, 1097-1101 (2007).
37. Suragani, R. N. et al. Transforming growth factor-beta superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis. Nature medicine 20, 408-414, doi: 10.1038/nm.3512 (2014).
38. Dussiot, M. et al. An activin receptor IIA ligand trap corrects ineffective erythropoiesis in beta-thalassemia. Nature medicine 20, 398-407, doi: 10.1038/nm.3468 (2014).